nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
|
Byrd, John C. |
|
|
135 |
15 |
p. 1204-1213 |
artikel |
2 |
Acetylsalicylic acid inhibits intravascular coagulation during Staphylococcus aureus–induced sepsis in mice
|
Carestia, Agostina |
|
|
135 |
15 |
p. 1281-1286 |
artikel |
3 |
Acetylsalicylic acid to fight thrombosis in sepsis
|
Ho-Tin-Noé, Benoit |
|
|
135 |
15 |
p. 1195-1196 |
artikel |
4 |
A few steps on the long road toward biomarkers in GVHD
|
Wolff, Daniel |
|
|
135 |
15 |
p. 1196-1197 |
artikel |
5 |
A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma
|
Pillarisetti, Kodandaram |
|
|
135 |
15 |
p. 1232-1243 |
artikel |
6 |
Baseline SUVmax did not predict histological transformation in follicular lymphoma in the phase 3 GALLIUM study
|
Mir, Farheen |
|
|
135 |
15 |
p. 1214-1218 |
artikel |
7 |
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression
|
Tissino, Erika |
|
|
135 |
15 |
p. 1244-1254 |
artikel |
8 |
Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs
|
Six, Emmanuelle |
|
|
135 |
15 |
p. 1219-1231 |
artikel |
9 |
Diagnostic bone marrow biopsy in patients with stage I EMZL treated with radiation therapy: needed or not?
|
Alderuccio, Juan Pablo |
|
|
135 |
15 |
p. 1299-1302 |
artikel |
10 |
Editorial Board
|
|
|
|
135 |
15 |
p. i |
artikel |
11 |
HIT: still stringing us along
|
Warkentin, Theodore E. |
|
|
135 |
15 |
p. 1193-1194 |
artikel |
12 |
Hotter is not more aggressive: baseline SUVmax in FL
|
Mikhaeel, N. George |
|
|
135 |
15 |
p. 1191-1192 |
artikel |
13 |
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies
|
Schultz, Kirk R. |
|
|
135 |
15 |
p. 1287-1298 |
artikel |
14 |
Mechanistic basis and efficacy of targeting the β-catenin–TCF7L2–JMJD6–c-Myc axis to overcome resistance to BET inhibitors
|
Saenz, Dyana T. |
|
|
135 |
15 |
p. 1255-1269 |
artikel |
15 |
Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation
|
Johnston, Ian |
|
|
135 |
15 |
p. 1270-1280 |
artikel |
16 |
The evolution of viral integration site analysis
|
Radtke, Stefan |
|
|
135 |
15 |
p. 1192-1193 |
artikel |
17 |
The fertile field of “isomopic” immune dysregulation as a nidus for lymphoproliferative disorders
|
Hsu, Andrew |
|
|
135 |
15 |
p. 1303 |
artikel |
18 |
The TEMPI syndrome
|
Sykes, David B. |
|
|
135 |
15 |
p. 1199-1203 |
artikel |